Alkem Launches Ibuprofen and Famotidine Tablets in the United States

Alkem Laboratories Ltd. (Alkem) today announced the launch of Ibuprofen and Famotidine Tablets (800 mg/26.6 mg) in the United States, following an approval from the United States Food and Drug Administration (US FDA). Ibuprofen and Famotidine Tablets is AB-rated generic therapeutic equivalent version of Horizon Medicines LLC's Duexis® Tablets, 800 mg/26.6 mg.

This is the first generic approval of Duexis® Tablets, 800 mg/26.6 mg by the US FDA. The launch is a subject of ongoing litigation.

Shares of Alkem Laboratories Limited was last trading in BSE at Rs. 3515 as compared to the previous close of Rs. 3483.05. The total number of shares traded during the day was 18442 in over 2138 trades.

The stock hit an intraday high of Rs. 3546 and intraday low of 3472.75. The net turnover during the day was Rs. 64700385.

Source : Equity Bulls

Keywords